BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

CDC Warning: Don't Use Amantadine Or Rimandatine To Treat Flu


1/16/2006 11:06:01 AM

The Centers for Disease Control yesterday issued an urgent health alert warning Americans not to rely on the antiviral drugs amantadine or rimantadine to treat influenza infection. The agency says a resistance to the medicines has developed in much of the US influenza A virus. Amantadine, however, is also used to treat Parkinson’s disease, and should continue to be used for this treatment. The discovery increases concern about preparedness for the bird flu, since the newer antiviral drugs – Tamiflu and Relenza – were being conserved for use in incidences of avian flu, if it should come to the US. Now, the government is recommending these two drugs be used for the treatment of seasonal flu. There is some concern a resistance to these drugs will now begin to develop. The older, and now ineffective drugs, worked only against the type A influenza but are less expensive and also available in generic forms. Tamiflu and Relenza work against type A and type B influenza and have shown some promise in treating bird flu. CDC officials held an unusual Saturday news conference to release the warning.

Read at Senior Journal
Read at Miami Herald
Read at Food Consumer
Read at New York Times
Read at The Age
Read at WebMD

   
Influenza

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES